Loading…
Pretreatment with troxerutin protects/improves neurological deficits in a mouse model of traumatic brain injury
Traumatic brain injury (TBI) is the major and leading cause of mortality and an alarming public health challenge. TBI leads to permanent cognitive, motor, sensory and psychotic disabilities. Patients suffering from the various and long-term repercussions of TBI currently have limited therapy choices...
Saved in:
Published in: | Heliyon 2023-07, Vol.9 (7), p.e18033-e18033, Article e18033 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c534t-ea63725aae5ae7fdec639facf7cb65980dc90d98858f73f23fa58019442c37c43 |
---|---|
cites | cdi_FETCH-LOGICAL-c534t-ea63725aae5ae7fdec639facf7cb65980dc90d98858f73f23fa58019442c37c43 |
container_end_page | e18033 |
container_issue | 7 |
container_start_page | e18033 |
container_title | Heliyon |
container_volume | 9 |
creator | Khan Malik, Ashfaq Ahmed Ahmad, Waqas Younas, Farhan Badshah, Haroon Alharazy, Shatha Rehman, Shafiq Ur Naseer, Muhammad Imran Yousef Muthaffar, Osama Achakzai, Rehmatullah Ullah, Ikram |
description | Traumatic brain injury (TBI) is the major and leading cause of mortality and an alarming public health challenge. TBI leads to permanent cognitive, motor, sensory and psychotic disabilities. Patients suffering from the various and long-term repercussions of TBI currently have limited therapy choices. The current research work was designed to evaluate the beneficial and neuroprotective role of Troxerutin (Trox) (a natural flavonoid) in a closed brain injury mouse model. The male BALB/c 8-weeks old mice (n꞊150) were randomly distributed in three experimental groups. Control group of mice (n꞊50), TBI group (n꞊50) and Trox pre-treated mice group (Trox + TBI, n꞊50). The mice in Trox + TBI were pre-treated with Trox (150 mg/kg, 7 days) before TBI. The weight-drop mechanism was used to induce mild-moderate injury in mice in both the groups. Our results showed that the mice pre-treated with troxerutin significantly improved neurological severity score, blood glucose level, food intake and brain edema as compared to the mice in the TBI group. Furthermore, compared to the TBI group, the mice treated with troxerutin improved cognitive behavior as evaluated by Open field test, Shallow Water Maze and Y-Maze, decreased brain-infarct volume and blood-brain barrier (BBB) permeability, significantly decreased Reactive Oxygen Species (ROS), improved neuronal morphology and survival in the brain regions such as cortex and hippocampus. In summary, our data provided evidence that pre-treatment with troxerutin improved neurological functions, decreased the BBB permeability, improved behavior, reduced ROS and increased neuronal survival in the weight-drop close head traumatic injury mouse model.
•Weight drop traumatic brain injury induced motor, sensory and behavioral abnormalities.•Troxerutin pre-treatment improved memory and reduced ROS/BBB leakage in TBI mice model.•Troxerutin pre-treatment reduced brain edema, improved food intake and neurological severity score.•Troxerutin pre-treatment increased neuronal survival in the brain against TBI induced neurodegeneration. |
doi_str_mv | 10.1016/j.heliyon.2023.e18033 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_43142a008f6e41c1820d87eddb14ef29</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2405844023052416</els_id><doaj_id>oai_doaj_org_article_43142a008f6e41c1820d87eddb14ef29</doaj_id><sourcerecordid>2841400287</sourcerecordid><originalsourceid>FETCH-LOGICAL-c534t-ea63725aae5ae7fdec639facf7cb65980dc90d98858f73f23fa58019442c37c43</originalsourceid><addsrcrecordid>eNqFUctu2zAQFIoWSZDkE1Lo2IsdviRSp6II-ggQoD2kZ2JNLm0KkuiSlFv_fenaTZNTL-RiOTs7nKmqG0qWlND2tl9ucPD7MC0ZYXyJVBHOX1UXTJBmoYQgr5_V59V1Sj0hhDaq7SQ_q865FIpLyS6q8C1ijgh5xCnXP33e1DmGXxjn7Kd6G0NGk9OtH0u5w1RPOMcwhLU3MNQWnTc-p7pAoR7DnLCcFoc6uEID8wjZm3oVoQD81M9xf1W9cTAkvD7dl9X3Tx8f774sHr5-vr_78LAwDRd5gdByyRoAbACls2ha3jkwTppV23SKWNMR2ynVKCe5Y9xBowjthGCGSyP4ZXV_5LUBer2NfoS41wG8_tMIca0hFnEDasGpYECIci0KaqhixCqJ1q6oQMe6wvX-yLWdVyNaU5yKMLwgffky-Y1eh52mhLeM8YOadyeGGH7MmLIefTI4DDBhcU0zJagghClZoM0RamJIKaJ72kOJPoSve30KXx_C18fwy9zb5yKfpv5G_e8XWGzfeYw6GY-TQetjybj44v-z4jfJOccQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2841400287</pqid></control><display><type>article</type><title>Pretreatment with troxerutin protects/improves neurological deficits in a mouse model of traumatic brain injury</title><source>Elsevier ScienceDirect Journals</source><source>PubMed Central</source><creator>Khan Malik, Ashfaq Ahmed ; Ahmad, Waqas ; Younas, Farhan ; Badshah, Haroon ; Alharazy, Shatha ; Rehman, Shafiq Ur ; Naseer, Muhammad Imran ; Yousef Muthaffar, Osama ; Achakzai, Rehmatullah ; Ullah, Ikram</creator><creatorcontrib>Khan Malik, Ashfaq Ahmed ; Ahmad, Waqas ; Younas, Farhan ; Badshah, Haroon ; Alharazy, Shatha ; Rehman, Shafiq Ur ; Naseer, Muhammad Imran ; Yousef Muthaffar, Osama ; Achakzai, Rehmatullah ; Ullah, Ikram</creatorcontrib><description>Traumatic brain injury (TBI) is the major and leading cause of mortality and an alarming public health challenge. TBI leads to permanent cognitive, motor, sensory and psychotic disabilities. Patients suffering from the various and long-term repercussions of TBI currently have limited therapy choices. The current research work was designed to evaluate the beneficial and neuroprotective role of Troxerutin (Trox) (a natural flavonoid) in a closed brain injury mouse model. The male BALB/c 8-weeks old mice (n꞊150) were randomly distributed in three experimental groups. Control group of mice (n꞊50), TBI group (n꞊50) and Trox pre-treated mice group (Trox + TBI, n꞊50). The mice in Trox + TBI were pre-treated with Trox (150 mg/kg, 7 days) before TBI. The weight-drop mechanism was used to induce mild-moderate injury in mice in both the groups. Our results showed that the mice pre-treated with troxerutin significantly improved neurological severity score, blood glucose level, food intake and brain edema as compared to the mice in the TBI group. Furthermore, compared to the TBI group, the mice treated with troxerutin improved cognitive behavior as evaluated by Open field test, Shallow Water Maze and Y-Maze, decreased brain-infarct volume and blood-brain barrier (BBB) permeability, significantly decreased Reactive Oxygen Species (ROS), improved neuronal morphology and survival in the brain regions such as cortex and hippocampus. In summary, our data provided evidence that pre-treatment with troxerutin improved neurological functions, decreased the BBB permeability, improved behavior, reduced ROS and increased neuronal survival in the weight-drop close head traumatic injury mouse model.
•Weight drop traumatic brain injury induced motor, sensory and behavioral abnormalities.•Troxerutin pre-treatment improved memory and reduced ROS/BBB leakage in TBI mice model.•Troxerutin pre-treatment reduced brain edema, improved food intake and neurological severity score.•Troxerutin pre-treatment increased neuronal survival in the brain against TBI induced neurodegeneration.</description><identifier>ISSN: 2405-8440</identifier><identifier>EISSN: 2405-8440</identifier><identifier>DOI: 10.1016/j.heliyon.2023.e18033</identifier><identifier>PMID: 37483772</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Brain injury ; Memory ; Neuroprotection ; Troxerutin</subject><ispartof>Heliyon, 2023-07, Vol.9 (7), p.e18033-e18033, Article e18033</ispartof><rights>2023 The Authors</rights><rights>2023 The Authors. Published by Elsevier Ltd.</rights><rights>2023 The Authors. Published by Elsevier Ltd. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c534t-ea63725aae5ae7fdec639facf7cb65980dc90d98858f73f23fa58019442c37c43</citedby><cites>FETCH-LOGICAL-c534t-ea63725aae5ae7fdec639facf7cb65980dc90d98858f73f23fa58019442c37c43</cites><orcidid>0000-0002-3458-1697 ; 0000-0001-8542-0810</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362234/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2405844023052416$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,27924,27925,45780,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37483772$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khan Malik, Ashfaq Ahmed</creatorcontrib><creatorcontrib>Ahmad, Waqas</creatorcontrib><creatorcontrib>Younas, Farhan</creatorcontrib><creatorcontrib>Badshah, Haroon</creatorcontrib><creatorcontrib>Alharazy, Shatha</creatorcontrib><creatorcontrib>Rehman, Shafiq Ur</creatorcontrib><creatorcontrib>Naseer, Muhammad Imran</creatorcontrib><creatorcontrib>Yousef Muthaffar, Osama</creatorcontrib><creatorcontrib>Achakzai, Rehmatullah</creatorcontrib><creatorcontrib>Ullah, Ikram</creatorcontrib><title>Pretreatment with troxerutin protects/improves neurological deficits in a mouse model of traumatic brain injury</title><title>Heliyon</title><addtitle>Heliyon</addtitle><description>Traumatic brain injury (TBI) is the major and leading cause of mortality and an alarming public health challenge. TBI leads to permanent cognitive, motor, sensory and psychotic disabilities. Patients suffering from the various and long-term repercussions of TBI currently have limited therapy choices. The current research work was designed to evaluate the beneficial and neuroprotective role of Troxerutin (Trox) (a natural flavonoid) in a closed brain injury mouse model. The male BALB/c 8-weeks old mice (n꞊150) were randomly distributed in three experimental groups. Control group of mice (n꞊50), TBI group (n꞊50) and Trox pre-treated mice group (Trox + TBI, n꞊50). The mice in Trox + TBI were pre-treated with Trox (150 mg/kg, 7 days) before TBI. The weight-drop mechanism was used to induce mild-moderate injury in mice in both the groups. Our results showed that the mice pre-treated with troxerutin significantly improved neurological severity score, blood glucose level, food intake and brain edema as compared to the mice in the TBI group. Furthermore, compared to the TBI group, the mice treated with troxerutin improved cognitive behavior as evaluated by Open field test, Shallow Water Maze and Y-Maze, decreased brain-infarct volume and blood-brain barrier (BBB) permeability, significantly decreased Reactive Oxygen Species (ROS), improved neuronal morphology and survival in the brain regions such as cortex and hippocampus. In summary, our data provided evidence that pre-treatment with troxerutin improved neurological functions, decreased the BBB permeability, improved behavior, reduced ROS and increased neuronal survival in the weight-drop close head traumatic injury mouse model.
•Weight drop traumatic brain injury induced motor, sensory and behavioral abnormalities.•Troxerutin pre-treatment improved memory and reduced ROS/BBB leakage in TBI mice model.•Troxerutin pre-treatment reduced brain edema, improved food intake and neurological severity score.•Troxerutin pre-treatment increased neuronal survival in the brain against TBI induced neurodegeneration.</description><subject>Brain injury</subject><subject>Memory</subject><subject>Neuroprotection</subject><subject>Troxerutin</subject><issn>2405-8440</issn><issn>2405-8440</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqFUctu2zAQFIoWSZDkE1Lo2IsdviRSp6II-ggQoD2kZ2JNLm0KkuiSlFv_fenaTZNTL-RiOTs7nKmqG0qWlND2tl9ucPD7MC0ZYXyJVBHOX1UXTJBmoYQgr5_V59V1Sj0hhDaq7SQ_q865FIpLyS6q8C1ijgh5xCnXP33e1DmGXxjn7Kd6G0NGk9OtH0u5w1RPOMcwhLU3MNQWnTc-p7pAoR7DnLCcFoc6uEID8wjZm3oVoQD81M9xf1W9cTAkvD7dl9X3Tx8f774sHr5-vr_78LAwDRd5gdByyRoAbACls2ha3jkwTppV23SKWNMR2ynVKCe5Y9xBowjthGCGSyP4ZXV_5LUBer2NfoS41wG8_tMIca0hFnEDasGpYECIci0KaqhixCqJ1q6oQMe6wvX-yLWdVyNaU5yKMLwgffky-Y1eh52mhLeM8YOadyeGGH7MmLIefTI4DDBhcU0zJagghClZoM0RamJIKaJ72kOJPoSve30KXx_C18fwy9zb5yKfpv5G_e8XWGzfeYw6GY-TQetjybj44v-z4jfJOccQ</recordid><startdate>20230701</startdate><enddate>20230701</enddate><creator>Khan Malik, Ashfaq Ahmed</creator><creator>Ahmad, Waqas</creator><creator>Younas, Farhan</creator><creator>Badshah, Haroon</creator><creator>Alharazy, Shatha</creator><creator>Rehman, Shafiq Ur</creator><creator>Naseer, Muhammad Imran</creator><creator>Yousef Muthaffar, Osama</creator><creator>Achakzai, Rehmatullah</creator><creator>Ullah, Ikram</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-3458-1697</orcidid><orcidid>https://orcid.org/0000-0001-8542-0810</orcidid></search><sort><creationdate>20230701</creationdate><title>Pretreatment with troxerutin protects/improves neurological deficits in a mouse model of traumatic brain injury</title><author>Khan Malik, Ashfaq Ahmed ; Ahmad, Waqas ; Younas, Farhan ; Badshah, Haroon ; Alharazy, Shatha ; Rehman, Shafiq Ur ; Naseer, Muhammad Imran ; Yousef Muthaffar, Osama ; Achakzai, Rehmatullah ; Ullah, Ikram</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c534t-ea63725aae5ae7fdec639facf7cb65980dc90d98858f73f23fa58019442c37c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Brain injury</topic><topic>Memory</topic><topic>Neuroprotection</topic><topic>Troxerutin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khan Malik, Ashfaq Ahmed</creatorcontrib><creatorcontrib>Ahmad, Waqas</creatorcontrib><creatorcontrib>Younas, Farhan</creatorcontrib><creatorcontrib>Badshah, Haroon</creatorcontrib><creatorcontrib>Alharazy, Shatha</creatorcontrib><creatorcontrib>Rehman, Shafiq Ur</creatorcontrib><creatorcontrib>Naseer, Muhammad Imran</creatorcontrib><creatorcontrib>Yousef Muthaffar, Osama</creatorcontrib><creatorcontrib>Achakzai, Rehmatullah</creatorcontrib><creatorcontrib>Ullah, Ikram</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Heliyon</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khan Malik, Ashfaq Ahmed</au><au>Ahmad, Waqas</au><au>Younas, Farhan</au><au>Badshah, Haroon</au><au>Alharazy, Shatha</au><au>Rehman, Shafiq Ur</au><au>Naseer, Muhammad Imran</au><au>Yousef Muthaffar, Osama</au><au>Achakzai, Rehmatullah</au><au>Ullah, Ikram</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pretreatment with troxerutin protects/improves neurological deficits in a mouse model of traumatic brain injury</atitle><jtitle>Heliyon</jtitle><addtitle>Heliyon</addtitle><date>2023-07-01</date><risdate>2023</risdate><volume>9</volume><issue>7</issue><spage>e18033</spage><epage>e18033</epage><pages>e18033-e18033</pages><artnum>e18033</artnum><issn>2405-8440</issn><eissn>2405-8440</eissn><abstract>Traumatic brain injury (TBI) is the major and leading cause of mortality and an alarming public health challenge. TBI leads to permanent cognitive, motor, sensory and psychotic disabilities. Patients suffering from the various and long-term repercussions of TBI currently have limited therapy choices. The current research work was designed to evaluate the beneficial and neuroprotective role of Troxerutin (Trox) (a natural flavonoid) in a closed brain injury mouse model. The male BALB/c 8-weeks old mice (n꞊150) were randomly distributed in three experimental groups. Control group of mice (n꞊50), TBI group (n꞊50) and Trox pre-treated mice group (Trox + TBI, n꞊50). The mice in Trox + TBI were pre-treated with Trox (150 mg/kg, 7 days) before TBI. The weight-drop mechanism was used to induce mild-moderate injury in mice in both the groups. Our results showed that the mice pre-treated with troxerutin significantly improved neurological severity score, blood glucose level, food intake and brain edema as compared to the mice in the TBI group. Furthermore, compared to the TBI group, the mice treated with troxerutin improved cognitive behavior as evaluated by Open field test, Shallow Water Maze and Y-Maze, decreased brain-infarct volume and blood-brain barrier (BBB) permeability, significantly decreased Reactive Oxygen Species (ROS), improved neuronal morphology and survival in the brain regions such as cortex and hippocampus. In summary, our data provided evidence that pre-treatment with troxerutin improved neurological functions, decreased the BBB permeability, improved behavior, reduced ROS and increased neuronal survival in the weight-drop close head traumatic injury mouse model.
•Weight drop traumatic brain injury induced motor, sensory and behavioral abnormalities.•Troxerutin pre-treatment improved memory and reduced ROS/BBB leakage in TBI mice model.•Troxerutin pre-treatment reduced brain edema, improved food intake and neurological severity score.•Troxerutin pre-treatment increased neuronal survival in the brain against TBI induced neurodegeneration.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>37483772</pmid><doi>10.1016/j.heliyon.2023.e18033</doi><orcidid>https://orcid.org/0000-0002-3458-1697</orcidid><orcidid>https://orcid.org/0000-0001-8542-0810</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2405-8440 |
ispartof | Heliyon, 2023-07, Vol.9 (7), p.e18033-e18033, Article e18033 |
issn | 2405-8440 2405-8440 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_43142a008f6e41c1820d87eddb14ef29 |
source | Elsevier ScienceDirect Journals; PubMed Central |
subjects | Brain injury Memory Neuroprotection Troxerutin |
title | Pretreatment with troxerutin protects/improves neurological deficits in a mouse model of traumatic brain injury |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T17%3A50%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pretreatment%20with%20troxerutin%20protects/improves%20neurological%20deficits%20in%20a%20mouse%20model%20of%20traumatic%20brain%20injury&rft.jtitle=Heliyon&rft.au=Khan%20Malik,%20Ashfaq%20Ahmed&rft.date=2023-07-01&rft.volume=9&rft.issue=7&rft.spage=e18033&rft.epage=e18033&rft.pages=e18033-e18033&rft.artnum=e18033&rft.issn=2405-8440&rft.eissn=2405-8440&rft_id=info:doi/10.1016/j.heliyon.2023.e18033&rft_dat=%3Cproquest_doaj_%3E2841400287%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c534t-ea63725aae5ae7fdec639facf7cb65980dc90d98858f73f23fa58019442c37c43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2841400287&rft_id=info:pmid/37483772&rfr_iscdi=true |